Cryoport, Inc. (NASDAQ:CYRX) Short Interest Down 7.4% in November

Cryoport, Inc. (NASDAQ:CYRX) was the target of a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 2,500,000 shares, a drop of 7.4% from the November 15th total of 2,700,000 shares. Currently, 5.3% of the company’s shares are sold short. Based on an average trading volume of 442,400 shares, the short-interest ratio is currently 5.7 days.

Insider Activity at Cryoport

In other Cryoport news, Director Ramkumar Mandalam sold 7,369 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $7.46, for a total transaction of $54,972.74. Following the completion of the sale, the director now directly owns 59,497 shares in the company, valued at $443,847.62. This represents a 11.02 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jerrell Shelton sold 50,000 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $6.51, for a total value of $325,500.00. Following the transaction, the chief executive officer now directly owns 731,897 shares of the company’s stock, valued at approximately $4,764,649.47. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 109,869 shares of company stock worth $735,673 in the last ninety days. Company insiders own 10.10% of the company’s stock.

Institutional Trading of Cryoport

Several institutional investors and hedge funds have recently bought and sold shares of CYRX. Comerica Bank increased its position in Cryoport by 73.0% in the 1st quarter. Comerica Bank now owns 3,481 shares of the company’s stock valued at $62,000 after acquiring an additional 1,469 shares during the period. The Manufacturers Life Insurance Company increased its position in Cryoport by 9.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,683 shares of the company’s stock valued at $122,000 after acquiring an additional 1,534 shares during the period. Rhumbline Advisers increased its position in Cryoport by 3.4% during the second quarter. Rhumbline Advisers now owns 64,158 shares of the company’s stock worth $443,000 after buying an additional 2,086 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Cryoport by 0.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 387,714 shares of the company’s stock worth $3,144,000 after acquiring an additional 2,226 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Cryoport during the third quarter valued at $82,000. 92.90% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Roth Mkm dropped their price objective on Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, November 8th. UBS Group boosted their target price on Cryoport from $7.00 to $9.00 and gave the stock a “neutral” rating in a research report on Friday, October 18th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, Cryoport currently has a consensus rating of “Moderate Buy” and an average target price of $12.50.

Cryoport Stock Up 3.6 %

Shares of NASDAQ:CYRX traded up $0.28 during trading on Tuesday, reaching $8.00. The stock had a trading volume of 130,261 shares, compared to its average volume of 558,427. The firm’s 50-day simple moving average is $7.31 and its 200 day simple moving average is $8.06. The company has a market capitalization of $395.45 million, a P/E ratio of -2.28 and a beta of 1.62. The company has a current ratio of 5.70, a quick ratio of 5.32 and a debt-to-equity ratio of 0.48. Cryoport has a one year low of $5.32 and a one year high of $20.10.

Cryoport Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.